ヘパリン化抗血栓性材料の生体適合性に関する臨床的検討 : 人工心肺中のサイトカイン, 血小板, 好中球活性の変動について
Atsushi Yamaguchi, 隆史 井野, Hideo Adachi et al. · 人工臓器 · 1995
Cited by 0 works. doi:10.11392/jsao1972.24.886
Authors
References
- Complement and the damaging effects of cardiopulmonary bypass
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal Residue
- Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
- Blood platelets in cardiopulmonary bypass operations
- Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma Experiments in the pig
- The Effect of Cardiopulmonary Bypass on T Cells and Their Subpopulations
- Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass
- Effect of cardiopulmonary bypass on circulating lymphocyte function